The increasing threat of Pseudomonas aeruginosa high-risk clones A Oliver, X Mulet, C López-Causapé, C Juan Drug Resistance Updates 21, 41-59, 2015 | 635 | 2015 |
β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver PLoS pathogens 5 (3), e1000353, 2009 | 325 | 2009 |
Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial Resistance A Doménech-Sánchez, L Martínez-Martínez, S Hernández-Allés, ... Antimicrobial agents and chemotherapy 47 (10), 3332-3335, 2003 | 273* | 2003 |
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals O Gutiérrez, C Juan, E Cercenado, F Navarro, E Bouza, P Coll, JL Pérez, ... Antimicrobial agents and chemotherapy 51 (12), 4329-4335, 2007 | 266 | 2007 |
Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains C Juan, MD Maciá, O Gutiérrez, C Vidal, JL Pérez, A Oliver Antimicrobial agents and chemotherapy 49 (11), 4733-4738, 2005 | 249 | 2005 |
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ... Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012 | 247 | 2012 |
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ... Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014 | 238 | 2014 |
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem E Riera, G Cabot, X Mulet, M García-Castillo, R del Campo, C Juan, ... Journal of antimicrobial chemotherapy 66 (9), 2022-2027, 2011 | 231 | 2011 |
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016 | 224 | 2016 |
Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD … C Juan, B Moyá, JL Pérez, A Oliver Antimicrobial agents and chemotherapy 50 (5), 1780-1787, 2006 | 217 | 2006 |
Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and … J Oteo, K Diestra, C Juan, V Bautista, Â Novais, M Pérez-Vázquez, ... International journal of antimicrobial agents 34 (2), 173-176, 2009 | 199 | 2009 |
Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic … A Oliver, BR Levin, C Juan, F Baquero, J Blázquez Antimicrobial agents and chemotherapy 48 (11), 4226-4233, 2004 | 180 | 2004 |
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa PA Fraile-Ribot, G Cabot, X Mulet, L Periañez, ML Martín-Pena, C Juan, ... Journal of Antimicrobial Chemotherapy 73 (3), 658-663, 2018 | 179 | 2018 |
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012 | 178 | 2012 |
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections C Juan, C Peña, A Oliver The Journal of infectious diseases 215 (suppl_1), S44-S51, 2017 | 158 | 2017 |
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ... Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013 | 143 | 2013 |
Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones C Juan, L Zamorano, A Mena, S Albertí, JL Pérez, A Oliver Journal of antimicrobial chemotherapy 65 (3), 474-478, 2010 | 137 | 2010 |
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 … E Viedma, C Juan, J Acosta, L Zamorano, JR Otero, F Sanz, F Chaves, ... Antimicrobial agents and chemotherapy 53 (11), 4930-4933, 2009 | 134 | 2009 |
Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after … B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010 | 130 | 2010 |
Benefit of Having Multiple ampD Genes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa B Moya, C Juan, S Albertí, JL Pérez, A Oliver Antimicrobial agents and chemotherapy 52 (10), 3694-3700, 2008 | 128 | 2008 |